Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome

Annals of Hematology

Volumn 82, Issue 4, 2003, Pages 236-240

  Takagi, K ^a   Yoshida, A ^a   Kinoshita, K ^a   Iwashima, D ^a   Imamaura, S ^a   Iwasaki, H ^a   Tsutani, H ^a   Ueda, T ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Acute mixed lineage leukemia; Bronchiolitis obliterans; Down syndrome; Graft versus host disease; Unrelated donor bone marrow transplantation

Indexed keywords

ACLARUBICIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ENOCITABINE; ETOPOSIDE; FIBRINOGEN RECEPTOR; IDARUBICIN; LYMPHOCYTE SURFACE MARKER; MERCAPTOPURINE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE; PREDNISOLONE; TACROLIMUS; UNINDEXED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BRONCHIOLITIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CASE REPORT; CELL PROLIFERATION; DISEASE SEVERITY; DONOR; DOWN SYNDROME; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; IMMUNOPEROXIDASE STAINING; LEUKOCYTE COUNT; MALE; MYELOBLAST; NEUTROPENIA; PERIODIC ACID SCHIFF STAIN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SKIN MANIFESTATION; STOMATITIS;

EID: 0038180695     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0617-1     Document Type: Article

References (23)

1. Avet-Loiseau H, Mechinaud F, Harrousseau JL (1995) Clonal hematologic disorders in Down syndrome. J Pediatr Hematol/Oncol 17:19-24
2. Baird PA, Sadovnick AD (1987) Life expectancy in Down syndrome. J Pediatr 110:849-854
3. Blatt J, Albo V, Prin W, Orlando S, Wollman M (1986) Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukemia. Lancet 2:914
4. Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N, Morilla R (1991) A classification of acute leukaemia for the 1990s. Ann Hematol 62:16-21
5. Crawford SW, Clark JG (1993) Bronchiolitis associated with bone marrow transplantation. Clin Chest Med 14:741-749
6. Drabkin HA, Erickson P(1995) Down syndrome and leukemia, an update. Prog Clin Biol Res 393:169-176
7. Garre ML, Relling MV, Kalwinsky D, Dodge R, Crom WR, Abromowitch M, Pui CH, Evans WE (1987) Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia. J Pediatr 111:606-612
8. Hayashi Y, Eguchi M, Sugita K, Nakazawa S, Sato T, Kojima S, Bessho F, Konishi S, Inaba T, Hanada R, Yamamoto K (1988) Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 72:15-23
9. Kojima S, Matsuyama T, Sato T, Horibe K, Konishi S, Tsuchida M, Hayashi Y, Kigasawa H, Akiyama Y, Okamura J, et al. (1990) Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 76:2348-2353
10. Krivit W, Good RA (1957) Simultaneous occurrence of mongolism and leukemia: report of nationwide survey. Am J Dis Child 94:289-293
11. Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, Gold S, Sanders J, Neudorf S, Smith FO, Woods WG (1998) Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 91:608-615
12. Pawlowska AB, Davies SM, Orchard PJ, Wagner JE, Ramsay NK (1996) Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome. Bone Marrow Transplant 18:453-455
13. Peeters M, Poon A (1987) Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity. Eur J Pediatr 146:416-422
14. Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF (1995) Post-transplant obstructive lung disease ("bronchiolitis obliterans"); a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 8:551-558
15. Ragab AH, Abdel-Mageed A, Shuster JJ, Frankel LS, Pullen J, van Eys J, Sullivan MP, Boyett J, Borowitz M, Crist WM (1991) Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study. Cancer 67:1057-1063
16. Ralph DD, Springmeyer SC, Sullivan KM, Hackman RC, Storb R, Thomas ED (1984) Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis 129:641-644
17. Ravindranath Y, Abella E, Krischer JP, Wiley J, Inoue S, Harris M, Chauvenet A, Alvarado CS, Dubowy R, Ritchey AK, Land V, Steuber CP, Weinstein H (1992) Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML study 8498. Blood 80:2210-2214
18. Ravindranath Y, Taub JW (1999) Down syndrome and acute myeloid leukemia. Lessons learned from experience with highdose Ara-C containing regimens. Adv Exp Med Biol 457:409-414
19. Robison LL (1992) Down syndrome and leukemia. Leukemia 6:5-7
20. Rubin CM, Mick R, Johnson FL (1996) Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome. Bone Marrow Transplant 18:533-540
21. Taub JW (2001) Relationship of chromosome 21 and acute leukemia in children with Down syndrome. J Pediatr Hematol Oncol 23:175-178
22. Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 359:1019-1025
23. Yoshida A, Ueda T, Urasaki Y, Seo T, Wano Y, Sugai S, Kamiya K, Kawase M, Katou T, Watanabe A, Haba T, Yamazaki Y, Ueda M, Kawamura Y, Kagawa D, Ohtake S, Matsuda T, Nakao S, Nakamura T (Hokuriku Hematology and Oncology Study Group) (2001) Randomised multicenter trial for comparison of two combination chemotherapy regimens including mitoxantrone or idarubicin in de novo acute myelogenous leukemia (in Japanese with English abstract). Rinsho Ketsueki 41:986